About LJL BioSystems
LJL BioSystems is a Healthcare company based in Sunnyvale (United States) founded in 1988, and was acquired by Molecular Devices in August 2000. Fluorescence detection instruments for life sciences are developed. Its focus areas include Biopharma Outsourcing, CRO and Drug Discovery. Its legal entity is LJL Biosystems Inc. Its competitors include Crown Bioscience, Alloy Therapeutics and NIH; 2 of its 3 listed competitors have raised funding.
Company details
LJL BioSystems was founded in 1988 in Sunnyvale, United States, within the biotechnology sector. Operations focus on the development and provision of advanced fluorescence detection systems used in life sciences research. Instruments are designed for applications in bioanalysis and high-throughput screening. The company maintains its base in the San Francisco Bay Area, serving global research needs in academic and industrial settings.
- Headquarters Sunnyvale, United States
- Stage Acquired
- SectorsHealthcare
- Website ljlbio.com
- Acquired by Molecular Devices (Aug 2000)
- Legal Name Ljl Biosystems Inc
- Investors
- Acquired byMolecular Devices
(Aug 2000)
Investors in LJL BioSystems
LJL BioSystems has secured backing from 1 investor. Prominent investors backing the company include Molecular Devices.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Automated life science research solutions are provided for various assays. | 1983 | moleculardevices.com | Sunnyvale, United States |
Investor details for LJL BioSystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of LJL BioSystems
2 dated milestones of LJL BioSystems across 12 years, from founding to its latest funding, stage changes and deals.
- Founded LJL BioSystems is founded.
- Exit Acquired by Molecular Devices.
Competitors of LJL BioSystems
LJL BioSystems has 3 listed competitors in our database, 2 of them funded. They include Crown Bioscience, Alloy Therapeutics and NIH.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| crownbio.com | 2006 | Santa Clara, United States | $85.87M | 18 | Cancer and CVMD drugs are developed using PDX models. | |
| alloytx.com | 2017 | Lexington, United States | $157M | Drug discovery services are provided for therapeutic development. | ||
| nih.gov | 1887 | United States | Drug discovery services are provided to the biopharma sector. |
Detailed competitors of LJL BioSystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as LJL BioSystems (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LJL BioSystems
LJL BioSystems was founded in 1988.
LJL BioSystems is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
LJL BioSystems was founded in 1988 in Sunnyvale, United States, within the biotechnology sector. Operations focus on the development and provision of advanced fluorescence detection systems used in life sciences research. Instruments are designed for applications in bioanalysis and high-throughput screening. The company maintains its base in the San Francisco Bay Area, serving global research needs in academic and industrial settings.
LJL BioSystems's top competitors include Crown Bioscience, NIH and Alloy Therapeutics.
LJL BioSystems has 1 investor. Key investors include Molecular Devices.
LJL BioSystems operates through Ljl Biosystems Inc.
Yes. LJL BioSystems was acquired by Molecular Devices in August 2000.